Well Lead Medical Co (603309.SS) Stock Price

Well Lead Medical Co Price

CLOSED
10.35
​
Market closed

Over the last 14 years Well Lead Medical Co grew revenue by 11.7% annually, reaching 1.63 B CNY. Earnings per share have grown at 3.4% per year over the last 14 years. For Well Lead Medical Co, the net margin of 4.7% is down versus 9.5% a few years ago. At today's price the dividend yield works out to roughly 4.83%. The payout ratio is around 193% of earnings. The dividend has grown at 15.8% per year over the past 10 years.

Well Lead Medical Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Well Lead Medical Co business model & stock analysis

Well Lead Medical Co., Ltd. generates revenue through the research, development, production, and sales of medical equipment for anesthesia, urology, nursing, respiratory, and hemodialysis applications. The company's major products include endotracheal intubations, urethral catheters, laryngeal masks, and hemodialysis catheters, which are used in clinical settings such as hospitals, surgeries, treatments, first aid, and nursing. Domestic and overseas markets are the primary channels for distributing these products, serving healthcare facilities that require specialized medical equipment for surgical procedures, emergency care, and patient treatment. The firm targets hospitals, surgical centers, and healthcare providers as key customers, leveraging its product range to address needs in anesthesia, urology, respiratory care, and hemodialysis. By focusing on clinical applications in surgery, treatment, emergency care, and nursing, Well Lead Medical ensures its equipment meets the demands of medical professionals across various hospital departments. The company's domestic and international distribution network supports its presence in both local and global healthcare markets.

Frequently asked questions about Well Lead Medical Co

5 analysts currently rate the Well Lead Medical Co stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Well Lead Medical Co to generate revenue of 1.85 B CNY and earnings per share of 0.91 CNY.

Converted at the current exchange rate, the Well Lead Medical Co share trades at 1.38 EUR (10.35 CNY).

The expected revenue of Well Lead Medical Co is 1.85 B CNY. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Well Lead Medical Co is 266.51 M CNY. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Well Lead Medical Co is currently 11.41. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Well Lead Medical Co stock.

The price-to-sales ratio (P/S) of Well Lead Medical Co is currently 1.65. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Well Lead Medical Co stock.

The Eulerpool Quality Score for Well Lead Medical Co is 8/10.

The ISIN of Well Lead Medical Co is CNE1000021C2. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Well Lead Medical Co is 603309.SS. The ticker symbol is used to trade Well Lead Medical Co shares on the stock exchange.

Fair ValueTerminal
9.83 CNY
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
628,583.82 CNY
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
CNY
Initial public offering
Mar 2, 2015
ISIN
CNE1000021C2
Cusip
Y95389105
Market capitalization
3.03 B CNYMid Cap
52-Week Range
PEG
3.31
P/E ratio
P/Ee 2026
11.37
P/Ee 2027
9.67
P/Ee 2028
8.09
P/S
P/Se
1.65
EV/EBIT
10.24
P/B Ratio
1.72
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
3.63 %
Dividend
Dividend yield
4.83 %
Est. Dividend Yield
8.12 %
Payout Ratio
192.52 %
Dividend growth Ø5Y
20.11 %
Dividend payments per year
1
Dividend paid since
9 years
Dividend not reduced since
3 years
Dividend increased since
0 years
Dividend withholding tax
10.00 %
Last updated Oct 24, 2026, 5:13 AM

Well Lead Medical Co Peer Group

Well Lead Medical Co FIGI

603309:CH · BBG001S2ZC07603309:CG · BBG006D09H13603309:C1 · BBG01FR9SD70